1-3 of 3
Raghavendra Gowda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5509: Natural occurring leelamine inhibits melanoma development by targeting multiple signaling pathways.

Raghavendra Gowda, SubbaRao V. Madhunapantula, Omer F. Kuzu, Arati Sharma, Robertson P. Gavin
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5509.
https://doi.org/10.1158/1538-7445.AM2013-5509
Published: 15 April 2013
View article titled, Abstract 5509: Natural occurring leelamine inhibits melanoma development by targeting multiple signaling pathways.
Journal Articles

Abstract 742: Development of novel naphthalimide derivatives as potential melanoma therapeutics

Ugir Hossain Sk, A.S. Prakasha Gowda, Melissa A. Gimbor, Raghavendra Gowda, Gavin P. Robertson, Thomas E. Spratt, Jong K. Yun, Shantu Amin, Arun K. Sharma
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 742.
https://doi.org/10.1158/1538-7445.AM10-742
Published: 15 April 2010
View article titled, Abstract 742: Development of novel naphthalimide derivatives as potential melanoma therapeutics
Journal Articles

Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development

Melissa A. Tran, Raghavendra Gowda, Arati Sharma, Eun-Joo Park, James Adair, Mark Kester, Nadine Barrie Smith, Gavin P. Robertson
Journal: Cancer Research
Cancer Res (2008) 68 (18): 7638–7649.
https://doi.org/10.1158/0008-5472.CAN-07-6614
Published: 14 September 2008
View article titled, Targeting <sup>V600E</sup>B-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development
Open the PDF for Targeting <sup>V600E</sup>B-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development in another window